Cintas saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 67 to 71.
IBD's proprietary rating measures market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price behavior over the last 52 weeks holds up against all the other stocks in our database.
Decades of market research shows that the market's biggest winners tend to have an 80 or higher RS Rating as they launch their biggest price moves. See if Cintas can continue to show renewed price strength and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
Cintas is trying to complete a consolidation with a 228.12 entry. See if the stock can break out in heavy trading.
The company saw both earnings and sales growth rise last quarter. Earnings-per-share increased from 18% to 21%. Revenue rose from 7% to 8%.
The company earns the No. 6 rank among its peers in the Commercial Services-Outsourcing industry group. ExlService Holdings, HealthEquity and Red Violet are among the top 5 highly rated stocks within the group.
RELATED:
Which Stocks Are Showing Improved Price Performance?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
